We also showed that a combination of cisplatin and the PI3K/mTOR inhibitor PKI‐402 induced LMP in HCC cells and then destroyed cisplatin‐induced mitochondrial‐lysosomal crosstalk, which significantly increased the sensitivity of HCC cells to cisplatin (Figure 7). This evidence concerns the gene PDLIM7 and hepatocellular carcinoma.